175 related articles for article (PubMed ID: 28875565)
1. Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score.
Bertoletti L; Robin P; Jara-Palomares L; Tromeur C; Pastre J; Prevot-Bitot N; Mouneh T; Le Gal G; Salaun PY;
J Thromb Haemost; 2017 Nov; 15(11):2184-2187. PubMed ID: 28875565
[TBL] [Abstract][Full Text] [Related]
2. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
[TBL] [Abstract][Full Text] [Related]
3. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
[TBL] [Abstract][Full Text] [Related]
4. Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis.
Mulder FI; Carrier M; van Doormaal F; Robin P; Otten HM; Salaun PY; Büller HR; Le Gal G; van Es N
J Thromb Haemost; 2020 Oct; 18(10):2622-2628. PubMed ID: 32654348
[TBL] [Abstract][Full Text] [Related]
5. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
[TBL] [Abstract][Full Text] [Related]
6. A clinical practice-based evaluation of the RIETE score in predicting occult cancer in patients with venous thromboembolism.
Rosell A; Lundström S; Mackman N; Wallén H; Thålin C
J Thromb Thrombolysis; 2019 Jul; 48(1):111-118. PubMed ID: 30739306
[TBL] [Abstract][Full Text] [Related]
7. External validation of the RIETE and SOME scores for occult cancer in patients with venous thromboembolism: a multicentre cohort study.
Franco-Moreno A; Morejón-Girón JB; Agudo-Blas P; de Ancos-Aracil CL; Muñoz-Rivas N; Farfán-Sedano AI; Ruiz-Ruiz J; Torres-Macho J; Bustamante-Fermosel A; Alfaro-Fernández N; Ruiz-Giardín JM; Madroñal-Cerezo E
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38724825
[TBL] [Abstract][Full Text] [Related]
8. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
[TBL] [Abstract][Full Text] [Related]
9. Prediction of short-term prognosis in elderly patients with acute pulmonary embolism: validation of the RIETE score.
Jaquet E; Tritschler T; Stalder O; Limacher A; Méan M; Rodondi N; Aujesky D
J Thromb Haemost; 2018 Jul; 16(7):1313-1320. PubMed ID: 29733493
[TBL] [Abstract][Full Text] [Related]
10. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Broderick C; Yeoh SE; Stansby G
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD010837. PubMed ID: 34597414
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer.
Li X; Hu Y; Lin P; Zhang J; Tang Y; Yi Q; Liang Z; Zhou H; Wang M
Thromb Haemost; 2021 Jun; 121(6):834-844. PubMed ID: 33450779
[TBL] [Abstract][Full Text] [Related]
12. External validation of the DASH prediction rule: a retrospective cohort study.
Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
[TBL] [Abstract][Full Text] [Related]
13. Prognosis in patients with cancer-associated venous thromboembolism: Comparison of the RIETE-VTE and modified Ottawa score.
Pfaundler N; Limacher A; Stalder O; Méan M; Rodondi N; Baumgartner C; Aujesky D
J Thromb Haemost; 2020 May; 18(5):1154-1161. PubMed ID: 32124545
[TBL] [Abstract][Full Text] [Related]
14. Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism.
Jara-Palomares L; Otero R; Jimenez D; Praena-Fernandez JM; Font C; Falga C; Soler S; Riesco D; Verhamme P; Monreal M;
PLoS One; 2018; 13(3):e0194673. PubMed ID: 29558509
[TBL] [Abstract][Full Text] [Related]
15. Occult cancer and thromboembolism: current epidemiology and its practical implications.
Chao CH; Wang HY; Kao CH
Pol Arch Intern Med; 2018 Sep; 128(9):539-544. PubMed ID: 30057385
[TBL] [Abstract][Full Text] [Related]
16. Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Alatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators T
Thromb Haemost; 2017 Jul; 117(8):1630-1636. PubMed ID: 28517021
[TBL] [Abstract][Full Text] [Related]
17. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.
Sun LM; Chung WS; Lin CL; Liang JA; Kao CH
J Thromb Haemost; 2016 Mar; 14(3):495-503. PubMed ID: 26748492
[TBL] [Abstract][Full Text] [Related]
18. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.
Nieto JA; Solano R; Trapero Iglesias N; Ruiz-Giménez N; Fernández-Capitán C; Valero B; Tiberio G; Bura-Riviere A; Monreal M;
Thromb Res; 2013 Aug; 132(2):175-9. PubMed ID: 23849097
[TBL] [Abstract][Full Text] [Related]
19. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2015 Mar; (3):CD010837. PubMed ID: 25749503
[TBL] [Abstract][Full Text] [Related]
20. Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism.
Scherz N; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Banyai M; Angelillo-Scherrer A; Lämmle B; Husmann M; Egloff M; Aschwanden M; Bounameaux H; Cornuz J; Rodondi N; Aujesky D
J Thromb Haemost; 2013 Mar; 11(3):435-43. PubMed ID: 23279158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
